Lorcan McGarvey

18.0k total citations · 6 hit papers
184 papers, 7.3k citations indexed

About

Lorcan McGarvey is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Lorcan McGarvey has authored 184 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Pulmonary and Respiratory Medicine, 125 papers in Physiology and 33 papers in Emergency Medical Services. Recurrent topics in Lorcan McGarvey's work include Respiratory and Cough-Related Research (128 papers), Asthma and respiratory diseases (98 papers) and Voice and Speech Disorders (34 papers). Lorcan McGarvey is often cited by papers focused on Respiratory and Cough-Related Research (128 papers), Asthma and respiratory diseases (98 papers) and Voice and Speech Disorders (34 papers). Lorcan McGarvey collaborates with scholars based in United Kingdom, United States and Australia. Lorcan McGarvey's co-authors include Surinder S. Birring, Kian Fan Chung, Alyn H. Morice, John A. Smith, Liam G. Heaney, Stuart B. Mazzone, Peter V. Dicpinigaitis, J. MacMahon, Robert A. Wise and Michael T. Zvarich and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lorcan McGarvey

177 papers receiving 7.1k citations

Hit Papers

ERS guidelines on the assessment of cough 2007 2026 2013 2019 2007 2019 2007 2021 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ERS guidelines on the assessment of cough
    2007 543 citations Alyn H. Morice, Maria G. Belvisi et al. European Respiratory Journal profile →
  2. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
    2019 475 citations Alyn H. Morice, Eva Millqvist et al. European Respiratory Journal profile →
  3. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
    2007 399 citations Lorcan McGarvey et al. Thorax profile →
  4. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses
    2021 222 citations Woo‐Jung Song, James H. Hull et al. profile →
  5. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
    2022 178 citations Lorcan McGarvey, Surinder S. Birring et al. profile →
  6. Cough hypersensitivity and chronic cough
    2022 147 citations Kian Fan Chung, Lorcan McGarvey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorcan McGarvey United Kingdom 42 6.0k 4.3k 1.1k 952 830 184 7.3k
Alyn H. Morice United Kingdom 48 8.4k 1.4× 7.0k 1.6× 1.9k 1.7× 1.4k 1.4× 1.6k 1.9× 343 11.0k
Peter V. Dicpinigaitis United States 38 4.5k 0.7× 3.6k 0.8× 1.1k 1.0× 665 0.7× 708 0.9× 169 5.5k
Surinder S. Birring United Kingdom 55 8.9k 1.5× 6.8k 1.6× 1.8k 1.7× 679 0.7× 1.2k 1.4× 272 10.3k
Woo‐Jung Song South Korea 36 3.0k 0.5× 3.2k 0.7× 892 0.8× 267 0.3× 391 0.5× 232 5.5k
D. Robin Taylor New Zealand 49 7.7k 1.3× 9.1k 2.1× 672 0.6× 96 0.1× 96 0.1× 106 11.6k
Emílio Pizzichini Brazil 41 7.7k 1.3× 8.9k 2.1× 854 0.8× 87 0.1× 92 0.1× 129 10.7k
Elisabeth H. Bel Netherlands 56 8.2k 1.4× 9.9k 2.3× 738 0.7× 208 0.2× 44 0.1× 162 12.3k
Søren Pedersen Denmark 33 5.2k 0.9× 6.0k 1.4× 408 0.4× 73 0.1× 35 0.0× 79 7.4k
César Picado Spain 49 2.8k 0.5× 4.4k 1.0× 167 0.2× 532 0.6× 33 0.0× 329 8.6k
E. Rand Sutherland United States 36 3.3k 0.5× 4.6k 1.1× 398 0.4× 60 0.1× 49 0.1× 62 6.6k

Countries citing papers authored by Lorcan McGarvey

Since Specialization
Citations

This map shows the geographic impact of Lorcan McGarvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorcan McGarvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorcan McGarvey more than expected).

Fields of papers citing papers by Lorcan McGarvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorcan McGarvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorcan McGarvey. The network helps show where Lorcan McGarvey may publish in the future.

Co-authorship network of co-authors of Lorcan McGarvey

This figure shows the co-authorship network connecting the top 25 collaborators of Lorcan McGarvey. A scholar is included among the top collaborators of Lorcan McGarvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorcan McGarvey. Lorcan McGarvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yeon-Hee, et al.. (2025). How Will a Treatable Traits Approach Reshape Clinical Practice in Chronic Cough?. Allergy Asthma and Immunology Research. 17(3). 304–304. 1 indexed citations
2.
Smith, John A., Surinder S. Birring, Michael S. Blaiss, et al.. (2025). Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). American Journal of Respiratory and Critical Care Medicine. 211(6). 1038–1048. 4 indexed citations
3.
Moe, Aung Aung Kywe, N. Singh, Matthew Dimmock, et al.. (2024). Brainstem processing of cough sensory inputs in chronic cough hypersensitivity. EBioMedicine. 100. 104976–104976. 17 indexed citations
4.
Kum, Elena, Gordon H. Guyatt, Rayid Abdulqawi, et al.. (2024). The McMaster Cough Severity Questionnaire (MCSQ): a cough severity instrument for patients with refractory chronic cough. European Respiratory Journal. 65(2). 2401565–2401565.
5.
Dunne, Orla M., Lorraine Martin, Gerard P. Sergeant, et al.. (2024). TRPV2 modulates mechanically Induced ATP Release from Human bronchial epithelial cells. Respiratory Research. 25(1). 188–188. 3 indexed citations
6.
Dicpinigaitis, Peter V., Alyn H. Morice, John A. Smith, et al.. (2023). Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study. Lung. 201(3). 255–266. 24 indexed citations
7.
Parker, Sean, John A. Smith, Surinder S. Birring, et al.. (2023). British Thoracic Society Clinical Statement on chronic cough in adults. Thorax. 78(Suppl 6). s3–s19. 29 indexed citations
8.
Smith, John A., James H. Hull, Surinder S. Birring, et al.. (2023). Randomized Proof-of-concept Study of AX-8, a TRPM8 Agonist, in Refractory or Unexplained Chronic Cough. A2532–A2532. 3 indexed citations
9.
McGarvey, Lorcan, John A. Smith, Surinder S. Birring, et al.. (2023). Response in Patient-reported Cough Severity in Soothe, a Phase 2b Trial of Camlipixant in Refractory Chronic Cough. A2533–A2533. 5 indexed citations
10.
Price, David, Rikke Buhl, Adrian Chan, et al.. (2018). The Role of FeNO in Cough Management : A Randomised Controlled Trial. Aberdeen University Research Archive (Aberdeen University). 1 indexed citations
11.
Belvisi, Maria G., Mark A. Birrell, Michael A. Wortley, et al.. (2017). XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough. American Journal of Respiratory and Critical Care Medicine. 196(10). 1255–1263. 121 indexed citations
12.
Hovi, Petteri, Betty R. Vohr, Laura R. Ment, et al.. (2016). Blood Pressure in Young Adults Born at Very Low Birth Weight: Adults Born Preterm International Collaboration. TNO Repository. 18 indexed citations
13.
Clarke, Rebecca, et al.. (2014). A Novel Human In Vitro Model for the Study of Nociceptive Responses in Sensory Nerves. Lung. 192(1). 4–5. 1 indexed citations
14.
Morice, Alyn H., Kian Fan Chung, Peter V. Dicpinigaitis, et al.. (2013). Cough hypersentivity syndrome: Preliminary findings of the ERS taskforce. European Respiratory Journal. 42(Suppl 57). P818–P818. 1 indexed citations
15.
Gough, Aisling, Mark Linden, Dale Spence, et al.. (2013). Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. European Respiratory Journal. 43(3). 808–816. 128 indexed citations
16.
Morice, Alyn H., Adam D Jakes, Shoaib Faruqi, et al.. (2013). Age And Sex Distribution Of Patients Presenting To Specialist Cough Clinics. American Journal of Respiratory and Critical Care Medicine. 187. 2 indexed citations
17.
18.
McGarvey, Lorcan, Andrea Koch, Alan Hamilton, et al.. (2013). 48-week administration of olodaterol QD via Respimat® vs placebo and formoterol BID in patients with COPD: Pooled safety analysis. European Respiratory Journal. 42(Suppl 57). P3633–P3633. 4 indexed citations
19.
Stevenson, Michael, et al.. (2012). The Utility of Fractional Exhaled Nitric Oxide Suppression in the Identification of Nonadherence in Difficult Asthma. American Journal of Respiratory and Critical Care Medicine. 186(11). 1102–1108. 130 indexed citations
20.
McGarvey, Lorcan, et al.. (2006). Prevalence of psychomorbidity among patients with chronic cough.. PubMed. 2(1). 4–4. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alyn H. Morice Breakdown of academic impact, for papers by Peter V. Dicpinigaitis Breakdown of academic impact, for papers by Surinder S. Birring Breakdown of academic impact, for papers by Woo‐Jung Song Breakdown of academic impact, for papers by D. Robin Taylor Breakdown of academic impact, for papers by Emílio Pizzichini Breakdown of academic impact, for papers by Elisabeth H. Bel Breakdown of academic impact, for papers by Søren Pedersen Breakdown of academic impact, for papers by César Picado Breakdown of academic impact, for papers by E. Rand Sutherland
Rankless by CCL
2026